MYX as a company now represents far less risk than it did before the Teva deal because of the diversity and number of products in its range. Don’t forget this deal had over 50 separate companies wanting in, but was given to Maynes after its due diligence and had to prove they had the capabilities and manufacturing facilities to get FTC approval in Washington.
Because Maynes now manufacture and distribute their products gives them far more control over the total business which in time will give them stronger sales growth and better profitability.
MYX is defiantly a growth stock of the future even though it has performed extremely well over the last 3 years where the management team has taking it from a $50M MC to over a $3 Billion company, but I believe the best is yet to come as they have many products still under FDA approval as well as other bolt on acquisitions.
Cheers Matsim
- Forums
- ASX - By Stock
- Target $1.93
MYX as a company now represents far less risk than it did before...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
|
|||||
Last
$5.16 |
Change
0.120(2.38%) |
Mkt cap ! $438.9M |
Open | High | Low | Value | Volume |
$5.07 | $5.34 | $5.02 | $2.193M | 421.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1431 | $5.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.16 | 1811 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 800 | 5.500 |
2 | 343 | 5.310 |
1 | 1260 | 5.300 |
1 | 99 | 5.250 |
1 | 34 | 5.130 |
Price($) | Vol. | No. |
---|---|---|
4.910 | 1272 | 2 |
5.160 | 1811 | 1 |
5.350 | 527 | 1 |
5.360 | 2720 | 1 |
5.380 | 5000 | 1 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online